Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Anthony V Moorman; Amir Enshaei; Daniel Murdy; Melvin Joy; Judith M Boer; Monique L den Boer; Rob Pieters; Valerie de Haas; Martin A Horstmann; Gabriele Escherich; Bertil Johansson; Hanne V Marquart; Kjeld Schmiegelow; Jeremy Hancock; John Moppett; Mats Heyman

doi:10.1038/s41375-024-02329-0

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Anthony V Moorman^*, Amir Enshaei, Daniel Murdy, Melvin Joy, Judith M Boer, Monique L den Boer, Rob Pieters, Valerie de Haas, Martin A Horstmann, Gabriele Escherich, Bertil Johansson, Hanne V Marquart, Kjeld Schmiegelow, Jeremy Hancock, John Moppett, Mats Heyman

^*Corresponding author for this work

Original language	English
Journal	Leukemia
Volume	38
Issue number	9
Pages (from-to)	2023-2026
Number of pages	4
ISSN	0887-6924
DOIs	https://doi.org/10.1038/s41375-024-02329-0
Publication status	Published - 2024

Keywords

Adolescent
Adult
Child
Female
Humans
Induction Chemotherapy
Male
Neoplasm, Residual/genetics
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics
Prognosis

Access to Document

10.1038/s41375-024-02329-0Licence: CC BY

Cite this

Moorman, A. V., Enshaei, A., Murdy, D., Joy, M., Boer, J. M., den Boer, M. L., Pieters, R., de Haas, V., Horstmann, M. A., Escherich, G., Johansson, B., Marquart, H. V., Schmiegelow, K., Hancock, J., Moppett, J., & Heyman, M. (2024). Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction. Leukemia, 38(9), 2023-2026. https://doi.org/10.1038/s41375-024-02329-0

Moorman, AV, Enshaei, A, Murdy, D, Joy, M, Boer, JM, den Boer, ML, Pieters, R, de Haas, V, Horstmann, MA, Escherich, G, Johansson, B, Marquart, HV , Schmiegelow, K, Hancock, J, Moppett, J & Heyman, M 2024, 'Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction', Leukemia, vol. 38, no. 9, pp. 2023-2026. https://doi.org/10.1038/s41375-024-02329-0

@article{b75b58f19be845fe890850f05dfc6a81,

title = "Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction",

keywords = "Adolescent, Adult, Child, Female, Humans, Induction Chemotherapy, Male, Neoplasm, Residual/genetics, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics, Prognosis",

author = "Moorman, {Anthony V} and Amir Enshaei and Daniel Murdy and Melvin Joy and Boer, {Judith M} and {den Boer}, {Monique L} and Rob Pieters and {de Haas}, Valerie and Horstmann, {Martin A} and Gabriele Escherich and Bertil Johansson and Marquart, {Hanne V} and Kjeld Schmiegelow and Jeremy Hancock and John Moppett and Mats Heyman",

year = "2024",

doi = "10.1038/s41375-024-02329-0",

language = "English",

volume = "38",

pages = "2023--2026",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

AU - Moorman, Anthony V

AU - Enshaei, Amir

AU - Murdy, Daniel

AU - Joy, Melvin

AU - Boer, Judith M

AU - den Boer, Monique L

AU - Pieters, Rob

AU - de Haas, Valerie

AU - Horstmann, Martin A

AU - Escherich, Gabriele

AU - Johansson, Bertil

AU - Marquart, Hanne V

AU - Schmiegelow, Kjeld

AU - Hancock, Jeremy

AU - Moppett, John

AU - Heyman, Mats

PY - 2024

Y1 - 2024

KW - Adolescent

KW - Adult

KW - Child

KW - Female

KW - Humans

KW - Induction Chemotherapy

KW - Male

KW - Neoplasm, Residual/genetics

KW - Precursor B-Cell Lymphoblastic Leukemia-Lymphoma/genetics

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85197502631&partnerID=8YFLogxK

U2 - 10.1038/s41375-024-02329-0

DO - 10.1038/s41375-024-02329-0

M3 - Letter

C2 - 38965371

SN - 0887-6924

VL - 38

SP - 2023

EP - 2026

JO - Leukemia

JF - Leukemia

IS - 9

ER -

Integration of genetics and MRD to define low risk patients with B-cell precursor acute lymphoblastic leukaemia with intermediate MRD levels at the end of induction

Keywords

Access to Document

Other files and links

Cite this